CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML

NCT04151706 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Leukemia
Chronic Myeloid Leukemia

Interventions

DRUG: CD8+ Memory T Cell Infusion
DRUG: Thiotepa
DRUG: Fludarabine
RADIATION: Hyperfractionated TBI
DRUG: Busulfan
DRUG: Cyclophosphamide

Sponsor

Robert Lowsky

Collaborators

[object Object]
[object Object]